Silphium Asset Management LTD Cytokinetics Inc Put Options Transaction History
Silphium Asset Management LTD
- $280 Billion
- Q3 2024
Put Options
2 transactions
Others Institutions Holding CYTK
# of Institutions
406Shares Held
125MCall Options Held
4.61MPut Options Held
2.46M-
Black Rock Inc. New York, NY14.7MShares$714 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$572 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD9.69MShares$471 Million0.31% of portfolio
-
Wellington Management Group LLP Boston, MA7.77MShares$378 Million0.07% of portfolio
-
State Street Corp Boston, MA6.46MShares$314 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $4.58B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...